Transaction Testing SWG
Minutes from the Conference Call Meeting held Thursday, June 6, 2002
The purpose of this call was to review the version of the Certification and
Compliance Testing White Paper currently being developed.
John quickly re-explained the rationale behind issuing an updated version
of Appendix A, without waiting for the rest of the completely revised
paper. The group feels that Appendix A is so obsolete, and inaccurate that
a more current copy needs to go to the website as soon as possible and not
be held up by the extensive changes to the entire paper.
John also looked for volunteers to take over "coordinatorship" /
"ownership", the original writers focuses' have broadened out into many
other areas. And again, there were no volunteers. John resigned to taking
over the assignment himself.
The tone of the document was the primary topic much of the call.
- being sure to include a 'vendor neutral' statement in the paper to
reiterate that we are not endorsing, sponsoring, or specifically singling
out one vendor over another. We are all volunteers who are employed by
organizations, some of these organizations are in a position, and are
philanthropic enough to take advantage of the position, to lend their
support in more ways than by offering volunteers. This additional support
should not be seen as an endorsement by WEDI SNIP of that organization or
its products.
- being sure the tone of the new version is toward 'validation'
downplaying 'certification'
This discussion led to another discussion about the approach to testing and
Type #7
- Should the approach involve just the Implementation Guides or the
Partner compliance agreements (so-called Companion Guides)
- Are Partner compliance agreements (so-called Companion Guides)
appropriate to the Business-To-Business Testing paper, while this
Compliance Testing paper should refer to the special payors/program testing
specifically referred to in the Rule (Medicare, Medicaid, Indian Health.)
- Examples were given to illustrate that validating companion testing and
the Guides have many of the same aspects including standards validation.
- Most on the call want the name/description for Type #7 changed
- It seemed to be generally accepted that the compliance testing paper
would refer the reader to the B-2-B paper and have a more thorough
discussion in that paper. However, we are going to stay focused on
completing and issuing the Compliance testing paper and not get sidetracked
with beginning to develop a new version of the B-2-B right now.
- Comments were also made regarding the misconception of Certification
being mandated.
Quoting from page 50342 of the TCS Final Rule:
"Since the HIPAA provisions do not require the Secretary to certify
compliance with HIPAA standards, the Secretary is not conducting
certification reviews or recognizing private organizations that have
decided to conduct such reviews. Therefore, any certification of commercial
entities performing validation testing will remain in the private domain
and be voluntary. While receivers of transactions are likely to test
whether a vendor that claims to be HIPAA compliant is, in fact, producing
compliant transactions, this is a matter of business practice, and such
tests are not being mandated in this rule."
John committed to issuing an updated document by the Monday before the next
call ... so Monday June 17.
The remainder of the time on the call was then turned over to Sanjeev
Kulkarni for a review of his concerns regarding Test Files received and
made available through SNIP. He talked about need to statements about the
objective, purpose and description to accompany each file. The Submitter
should also identify who validated the material in the file. This way
entities who were interested in Home Infusion Therapy Tests would be able
to pick these files and not "waste" test time by picking a test file with
Ambulance Claims. Claredi has indicated that they have adequate storage
available for the 'public' to submit their test files, and we won't have to
link to multiple sites.
Sanjeev will write and distribute his suggestions for us to review before
the next call.
The tentative agenda for the next call ... Thursday June 20th ... 8 AM
Pacific ... 11 AM Eastern at 703.736.7290 pass code 1315339
Review Compliance Testing White Paper
- John's updates as well as
- Sanjeev's review
Review of Sanjeev's Test File recommendations
If you have any questions, or your notes don't agree with mine, please let
me know.
Marsha
Verizon Information Technologies Inc.
Managed Care Division
Phoenix, AZ
HOME OF THE WORLD CHAMPION ARIZONA DIAMONDBACKS
Phone - 602.678.6042
Fax - 602.678.6331
E-mail - [EMAIL PROTECTED]
Confidentiality Notice: This e-mail message, including any attachments, is
for the sole use of the intended recipient(s) and may contain confidential
and privileged information. Any unauthorized review, use, disclosure or
distribution is prohibited. If you are not the intended recipient, please
contact the sender by reply e-mail and destroy all copies of the original
message.
**********************************************************************
To be removed from this list, send a message to: [EMAIL PROTECTED]
Please note that it may take up to 72 hours to process your request.
